Sec. 403. Green health care manufacturing
592 words·~3 min read·
/bill/118/s/1229/is/section-403·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
There is established a Federal interagency working group, to be known as the Council on Green Health Care Manufacturing (referred to in this section as the Council ). The membership of the Council shall consist of— the Secretary of Health and Human Services (referred to in this section as the Secretary ), who shall serve as the Chair; the Secretary of Energy; the Secretary of Transportation; the Secretary of Labor; the Administrator of the Environmental Protection Agency; the Director of the Office of Climate Change and Health Equity; the Director of Sustainability and Environmental Impact; the Chair of the Council on Environmental Quality; the United States Trade Representative; and the heads of other Federal agencies, as determined necessary by the Chair.
Not later than 1 year after the date of enactment of this Act, the Council shall conduct an assessment of global and domestic medical supply chains, including an assessment of— the environmental and climate impacts of medical supply chains, including— emissions from the production, transportation, and packaging of medical and pharmaceutical products; chemical and other environmental pollution; excessive energy consumption; negative externalities relating to waste; and any other environmental or climate impacts the Council determines relevant; labor conditions for workers in the United States and globally who produce medical and pharmaceutical products consumed by individuals residing in the United States, including the degree to which such workers— are ensured a protected right to organize; are provided adequate workplace safety protections; and are adequately compensated; efficiency and resiliency of processes under medical supply chains, including the ability of medical supply chains to adapt to sudden shifts in demand, including shifts in demand within discrete geographic regions; the reliance of the United States on international supply chains for medical products, including information about which types of medical products are primarily manufactured outside of the United States, and where such products are manufactured; and human rights abuses in manufacturing of medical and pharmaceutical products and sourcing of those products, including abuses of indigenous rights and traditions.
On completion of the assessment conducted under subparagraph (A), the Council shall submit to Congress and make publicly available a report, to be known as the Green Health Care Manufacturing Report , that describes the findings of the assessment. Based on the findings of the assessment conducted under paragraph (1)(A), the Council shall develop recommendations for regulations that would support a medical supply chain that is— sustainable; free of greenhouse gas emissions; and based in the United States.
The proposed regulations under subparagraph
(A)shall— support good labor conditions, worker protections, and employee rights to organize and collectively bargain; and ensure the global trade competitiveness of the United States, including by considering the comparative carbon intensity of domestic and internationally manufactured pharmaceuticals and medical products. Based on the findings of the assessment conducted under paragraph (1)(A), the Council shall develop recommendations for a grant program to be carried out by the Secretary under which the Secretary would make grants for medical manufacturing to support the development and establishment of sustainable and zero-emission medical supply chains based in the United States. Not later than 1 year after the date of enactment of this Act, the Secretary shall develop and promulgate regulations to support a medical supply chain that is— sustainable; free of greenhouse gas emissions; and based in the United States. The Secretary shall develop the regulations under paragraph
(1)based on the recommendations for regulations developed by the Council under subsection (c)(2). There are authorized to be appropriated to carry out this section such sums as are necessary.